26Aug
Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By:
Robins Kaplan LLP
Related
On September 15, 2020, the U.S. Department of the Treasury published a final rule, effective October...
Read More >
In Caesars Entertainment d/b/a Rio All-Suites Hotel and Casino, Case 28-CA-060841 (December 16, 2019...
Read More >
Employers using non-disparagement agreements could be under scrutiny after some recent guidance from...
Read More >
Charles Schwab, the largest publicly traded discount brokerage firm and of the largest custodian of ...
Read More >
Companies that rely on mergers and acquisition for growth have to build robust post-acquisition inte...
Read More >
Industry Expert Insights - We reached out to one of our Lex Mundi partners and a well-known expert...
Read More >